Pharmaceutical startup Bridge Therapeutics announces the addition of Dr. Bob Raffa as its newest Scientific Advisory Board member.
Janssen's Tremfya continues to post gains, but may soon face competition as Sun Dermatology readies for the launch of Ilumya (tildrakizumab), the second IL-23 inhibitor to be introduced in the U.S. market, according to a new report from Spherix Global Insights
Alpha Genesis initiative with important medical research implications
Masy, a leading provider of quality solutions for Life Sciences, is now offering precision products from SenseAnywhere and Insatech
Study aims to identify novel blood-based inflammatory markers that can be used to both identify and stratify Parkinson's disease patients
Pharmaceutical development is inherently risky. To develop a molecule that has a desired, efficacious, but safe, effect in humans is a remarkable achievement considering the statistics.
Earlier this year, two fertility clinics experienced liquid nitrogen tank failures and thousands of eggs and embryos were compromised. These two catastrophic incidents highlight the risks associated with the storage and transportation of human reproductive materials including sperm, eggs and embryos.
According to the new market research report launched by Inkwood Research, The Global Pharmaceutical Desiccant market was valued at nearly $127650 million in 2017 and is anticipated to reach around $188150 million by 2026, growing at an estimated CAGR of 4.39% during the forecast period 2018-2026.
Clinical Pipe allows patient data to be exported directly from a clinical site's EHR and transferred into clinical research EDC.
InDevR's VaxArray® vaccine potency testing platform now includes a reagent kit for rapid assessment of neuraminidase in influenza vaccines
According to the new market research report launched by Inkwood Research, The Global CRISPR Market was valued around $ 500 million in 2017 and is anticipated to reach 8000 million by 2026, growing at an estimated CAGR of 36.53%, during the forecast period 2018-2026.
One of America's foremost oncologists leads this webinar series on the past, the present and the future of immunotherapy studies
The focus on technology as a driver of performance improvement in clinical trials is intense, but despite years of valiant efforts, study execution remains far from optimal - for study startup, the data are dismal
Industry experts will tackle the challenge of recruiting patients with early stage Alzheimer's disease into clinical trials to expedite treatment development